Skip to main content
. 2022 Jul 28;24(4):542–551. doi: 10.1093/ehjci/jeac151

Table 3.

Clinical and echocardiographic characteristics of the phenotype-negative population

Total LVH- (N = 84) Sarc LVH- (N = 56) GLA LVH- (N = 28) P-value*
Demographic characteristics
ȃAge (years) 39 ± 15 37 ± 15 40 ± 15 0.337
ȃFemale (n,%) 57 (68) 38 (68) 19 (68) 1.000
ȃHypertension (n,%) 15 (18) 9 (16) 6 (21) 0.546
Echocardiographic characteristics
ȃLV mass index (g/m2) 80 (68–93) 80 (69–92) 78 (66–93) 0.708
ȃLVEDV index (mL/m2) 49 (43–54) 51 (45–56) 47 (40–52) 0.256
ȃLVEF (%) 63 ± 5 63 ± 6 64 ± 3 0.258
ȃLV-GLS (%) 21.8 (19.9–23.2) 22.3 (20.6–23.7) 20.2 (18.5–22.0) 0.002
ȃLAV index (mL/m2) 28 (23–32) 27 (23–33) 29 (24–30) 1.000
ȃE/A ratio 1.3 (1.1–1.7) 1.3 (1.1–1.5) 1.6 (1.3–1.9) 0.013
ȃE/E′ ratio 7.1 (5.8–8.6) 7.9 (6.0–9.3) 6.3 (5.4–7.3) 0.001
ȃRVWT (mm) 3.5 (3.0–4.0) 3.5 (3.0–4.0) 3.6 (3.2–4.0) 0.747
ȃRVEDA (cm2) 16.4 (14.2–19.3) 16.9 (14.1–19.3) 15.1 (14.5–18.6) 0.407
ȃRVESA (cm2) 8.3 (6.5–9.7) 8.3 (6.5–9.7) 8.0 (6.3–10.6) 0.859
ȃRAV index (ml/m2) 14 (11–19) 15 (11–19) 14 (11–19) 0.772
ȃTAPSE (mm) 24 ± 3 24 ± 3 23 ± 3 0.745
ȃRVFAC (%) 51 ± 6 51 ± 6 51 ± 6 0.817
ȃRV S′ velocity (cm/s) 13.4 ± 2.2 13.2 ± 3.0 13.5 ± 1.5 0.669
ȃRV-GLS (%) 24.9 (22.2–27.4) 25.3 (22.9–28.0) 23.5 (21.8–26.0) 0.049
ȃRV-FWS (%) 29.2 (26.6–32.6) 30.3 (27.5–33.4) 26.6 (23.9–29.6) <0.001
ȃΔRV strain (%) 4.3 (2.8–5.9) 5.0 (3.3–7.0) 2.9 (2.0–4.3) <0.001
ȃTR jet velocity (m/s) 2.1 (2.0–2.3) 2.1 (2.0–2.3) 2.1 (2.0–2.4) 0.989

Comparison of echocardiographic parameters was performed applying a Bonferroni correction. P values <0.0028 were considered statistically significant (18 comparisons) and are shown in bold type.

LAV, left atrial volume; LVEDV, LV end diastolic volume; RAV, right atrial volume; RVEDA, RV end-diastolic area; RVESA, RV end-systolic area; RVWT, RV wall thickness; TR, tricuspid regurgitation.